HELQ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.180000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.507600E-01
Normal-vs-Stage2
2.390000E-02
Normal-vs-Stage3
1.118400E-01
Normal-vs-Stage4
6.755000E-01
Stage1-vs-Stage2
5.484400E-01
Stage1-vs-Stage3
1.874360E-01
Stage1-vs-Stage4
4.174000E-01
Stage2-vs-Stage3
2.641600E-01
Stage2-vs-Stage4
1.021560E-01
Stage3-vs-Stage4
1.101590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.402400E-02
Normal-vs-AfricanAmerican
1.918220E-01
Normal-vs-Asian
3.715800E-02
Caucasian-vs-AfricanAmerican
9.896600E-01
Caucasian-vs-Asian
2.187400E-01
AfricanAmerican-vs-Asian
4.136400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.408000E-02
Normal-vs-Female
4.211600E-02
Male-vs-Female
6.574000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.346000E-01
Normal-vs-Age(41-60Yrs)
4.098800E-01
Normal-vs-Age(61-80Yrs)
3.272500E-02
Normal-vs-Age(81-100Yrs)
3.478800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.576400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.871600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.045400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.078000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.586000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.516400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.406130E-02
Normal-vs-Daily Drinker
1.219700E-02
Normal-vs-Weekly Drinker
1.738310E-02
Normal-vs-Occasional Drinker
1.624040E-01
Normal-vs-Social Drinker
1.895240E-01
Non Drinker-vs-Daily Drinker
8.490000E-01
Non Drinker-vs-Weekly Drinker
7.514800E-01
Non Drinker-vs-Occasional Drinker
6.781700E-02
Non Drinker-vs-Social Drinker
1.854970E-01
Daily Drinker-vs-Weekly Drinker
8.808000E-01
Daily Drinker-vs-Occasional Drinker
5.631900E-02
Daily Drinker-vs-Social Drinker
1.612200E-01
Weekly Drinker-vs-Occasional Drinker
6.895500E-02
Weekly Drinker-vs-Social Drinker
1.803840E-01
Occasional Drinker-vs-Social Drinker
8.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.053000E-01
Normal-vs-Grade 2
6.671900E-02
Normal-vs-Grade 3
7.767600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.263400E-01
Grade 1-vs-Grade 3
5.517000E-01
Grade 1-vs-Grade 4
2.053000E-01
Grade 2-vs-Grade 3
7.865600E-01
Grade 2-vs-Grade 4
6.671900E-02
Grade 3-vs-Grade 4
7.767600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.174600E-01
Normal-vs-NonDiabetic
1.364440E-02
Diabetic-vs-NonDiabetic
6.623000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.827400E-01
Normal-vs-NoPancreatitis
1.917750E-02
Pancreatitis-vs-NoPancreatitis
5.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.108370E-01
Normal-vs-N1
2.255800E-02
N0-vs-N1
2.344200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.620100E-02
Normal-vs-TP53-NonMutant
1.511630E-01
TP53-Mutant-vs-TP53-NonMutant
3.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
